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Background:  Contrast echocardiography has been shown to improve endocardial border visualization and also increase the sensitivity in 
detecting left ventricular thrombus. In October 2007, the Federal Drug Agency issued a black box warning for contrast agents used in patients 
undergoing echocardiography. This safety concern has been disproven by several studies. We aim to provide data to support the safety of ultrasound 
contrast and demonstrate an expanded role of contrast agents in the diagnosis of atrial thrombi.
Methods:  We retrospectively reviewed 200 consecutive patients who underwent transesophageal echo (TEE) with contrast (Definity, Optison) 
and 200 patients without contrast in the setting of atrial fibrillation/flutter for detection of left atrial appendage thrombus. We collected data on 
sex, age, detection of thrombi, transient ischemic attack (TIA) or stroke within six months of TEE, and side effects to contrast. The 200 patients who 
received contrast with TEE dated from June 2011 to April 2004. The 200 patients who did not receive contrast had a TEE between May 2011 and 
September 2009.
Results:  In the TEE with contrast group, 158 patients had atrial fibrillation and 42 patients with atrial flutter. In addition, Definity was given to 
83 patients and Optison to 117 patients. 71% were males and 29% were females with a mean age of 66. The detection rate of thrombus in this 
population was 22/200 (11%). None of these patients had a stroke or TIA within six months of the TEE with contrast nor experienced side effects 
from the contrast. In the non-contrast TEE group, 135 and 65 patients had the diagnosis of atrial fibrillation and atrial flutter, respectively. 65% were 
males and 35% were females with a mean age of 62.5. Thrombus was detected in 14/200 (7%). None of these patients had a stroke or TIA within 6 
months.
Conclusion:  Our data support prior studies concerning the safety of ultrasound contrast. In addition, patients who received contrast had a 
thrombi detection rate of 11% compared to 7% who did not receive contrast (p = 0.025). Although TEE alone is quite sensitive for detection of 
thrombus, our data suggest that there may be an incremental value for the addition of contrast in the detection of atrial thrombi.
